{"schema":"sb.node.v1","id":"sb:e/66c490e86406515869f442bf","kind":"entity","label":{"text":"duchenne","locale":"en"},"identity":{"anchor":"label:en:duchenne","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-08T17:31:13.825968+00:00","snapshot":"deploy 0213c6200d34bd9327cf8fb2d5bb00702183a24b"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":28,"separatePublishers":15,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-05-01","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.179: about 82% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto","rare_diseases"],"activeDays":20,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/2c54babaf084a2cb5f90a45c","kind":"observation","label":"STAT News · 2026-10-07 · STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few","url":"https://www.statnews.com/2026/10/07/muscular-dystrophy-exon-skipping-drugs-novartis-dyne/?utm_campaign=rss"},{"id":"sb:o/64375da6e94d0220cb9c9bcc","kind":"observation","label":"PR Newswire · 2026-10-03 · Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrop…","url":"https://www.prnewswire.com/news-releases/ractigen-therapeutics-presents-positive-first-in-human-data-for-rag-18-at-wms-2026-establishing-clinical-proof-of-mechanism-for-rna-activation-in-duchenne-muscular-dystrophy-302897620.html"},{"id":"sb:o/ebbc36b47575b8a0f931677a","kind":"observation","label":"Chemical & Engineering News · 2026-09-22 · Restoring dystrophin in mice with Duchenne muscular dystrophy","url":"https://cen.acs.org/biological-chemistry/rna/suppressor-trna-muscular-dystrophy-tevard-biosciences/104/web/2026/09?sc=230901_cenrssfeed_eng_latestnewsrss_cen"},{"id":"sb:o/ce085627e86b02f5303b2750","kind":"observation","label":"GEN · 2026-09-06 · NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy","url":"https://www.genengnews.com/topics/bioprocessing/newbiologix-and-synastra-join-forces-to-advance-raav-manufacturing-for-duchenne-gene-therapy/"},{"id":"sb:o/f2b87971960fae76eca9a6d3","kind":"observation","label":"MarketBeat News Feed · 2026-10-07 · Sarepta Therapeutics (NASDAQ:SRPT) Downgraded by Zacks Research to \"Strong Sell\"","url":"https://www.marketbeat.com/instant-alerts/analyst-sarepta-therapeutics-nasdaq-srpt-downgraded-by-zacks-research-to-strong-sell-2026-10-07/"},{"id":"sb:o/0eaeff9ec30f2a6ba44786de","kind":"observation","label":"STAT News · 2026-10-07 · ER visits from people born outside the U.S. dropped after ICE raids","url":"https://www.statnews.com/2026/10/07/health-news-er-visits-from-people-born-outside-the-u-s-dropped-after-ice-raids/?utm_campaign=rss"},{"id":"sb:o/d7ffe89a57b6b1afd03984d4","kind":"observation","label":"AllSci News · 2026-10-06 · Italfarmaco and VeriSIM Life combine AI and HDAC expertise in USD 100m+ drug discovery deal","url":"https://allsci.com/news/biotech/hdac-drug-discovery-italfarmaco-and-verisim-life/"},{"id":"sb:o/5ec3bd608c9137d784026c08","kind":"observation","label":"MarketBeat News Feed · 2026-10-05 · Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Reaffirmed as Sell by HC Wainwright","url":"https://www.marketbeat.com/instant-alerts/analyst-sarepta-therapeutics-srpt-sell-rating-reiterated-at-hc-wainwright-2026-10-05/"},{"id":"sb:o/5da1cdc668ffd3742fea399a","kind":"observation","label":"MarketBeat News Feed · 2026-10-03 · PTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock","url":"https://www.insidertrades.com/alerts/nasdaq-ptct-insider-buying-and-selling-2026-10-03/"},{"id":"sb:o/6c03996dbe620666d10bcb93","kind":"observation","label":"Peter Attia · 2026-10-03 · Myostatin inhibitors and the paradox of larger but weaker muscles","url":"https://peterattiamd.com/myostatin-inhibitors-and-larger-but-weaker-muscles/"}],"cursor":"c1.eyJpZCI6InNiOmUvNjZjNDkwZTg2NDA2NTE1ODY5ZjQ0MmJmIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA4VDE3OjMxOjEzLjgyNTk2OCswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":4,"byKind":{"co-mentioned":4},"items":[{"kind":"relation","label":"co-mentioned with fda (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/9d245f8898ddbb2dd19a5452"},{"kind":"relation","label":"co-mentioned with gene therapy (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/28a966d1bc536da6e1f87c1f"},{"kind":"relation","label":"co-mentioned with nasdaq (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/8b0d22717873bc4596352b4c"},{"kind":"relation","label":"co-mentioned with buy (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/6d3cc5d52187551ccc884cf3"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/66c490e86406515869f442bf","mcp":"traverse {\"id\":\"sb:e/66c490e86406515869f442bf\"}","page":"/entity/duchenne/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/66c490e86406515869f442bf\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/66c490e86406515869f442bf\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/66c490e86406515869f442bf\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/66c490e86406515869f442bf\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}